Cite
HARVARD Citation
Yoo, D. et al. (2017). Efficacy and safety of CT-P13 (biosimilar infliximab) in patients with rheumatoid arthritis: comparison between switching from reference infliximab to CT-P13 and continuing CT-P13 in the PLANETRA extension study. Annals of the rheumatic diseases. 76 (2), pp. 355-363. [Online].